Global Stimulants Drugs Industry Market Research Report

August 2017 | 144 pages | ID: G6B808DD16BEN
Maia Research

Abstracts

Based on the Stimulants Drugs industrial chain, this report mainly elaborate the definition, types, applications and major players of Stimulants Drugs market in details. Deep analysis about market status (2012-2017), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2017-2022), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Stimulants Drugs market.

The Stimulants Drugs market can be split based on product types, major applications, and important regions.

Major Players in Stimulants Drugs market are:

NEOS Therapeutics
Teva
Shire
Novartis
Arbor Pharmaceuticals
Noven Therapeutics
Janssen
Amedra Pharms
Tocris

Major Regions play vital role in Stimulants Drugs market are:

North America
Europe
China
Japan
Middle East & Africa
India
South America
Others

Most important types of Stimulants Drugs products covered in this report are:

Tablet
Injection

Most widely used downstream fields of Stimulants Drugs market covered in this report are:

Adult
Child

Contents

1 STIMULANTS DRUGS INTRODUCTION AND MARKET OVERVIEW

1.1 Objectives of the Study
1.2 Definition of Stimulants Drugs
1.3 Stimulants Drugs Market Scope and Market Size Estimation
  1.3.1 Market Concentration Ratio and Market Maturity Analysis
  1.3.2 Global Stimulants Drugs Value ($) and Growth Rate from 2012-2022
1.4 Market Segmentation
  1.4.1 Types of Stimulants Drugs
  1.4.2 Applications of Stimulants Drugs
  1.4.3 Research Regions
    1.4.3.1 North America Stimulants Drugs Production Value ($) and Growth Rate (2012-2017)
    1.4.3.2 Europe Stimulants Drugs Production Value ($) and Growth Rate (2012-2017)
    1.4.3.3 China Stimulants Drugs Production Value ($) and Growth Rate (2012-2017)
    1.4.3.4 Japan Stimulants Drugs Production Value ($) and Growth Rate (2012-2017)
    1.4.3.5 Middle East & Africa Stimulants Drugs Production Value ($) and Growth Rate (2012-2017)
    1.4.3.6 India Stimulants Drugs Production Value ($) and Growth Rate (2012-2017)
    1.4.3.7 South America Stimulants Drugs Production Value ($) and Growth Rate (2012-2017)
1.5 Market Dynamics
  1.5.1 Drivers
    1.5.1.1 Emerging Countries of Stimulants Drugs
    1.5.1.2 Growing Market of Stimulants Drugs
  1.5.2 Limitations
  1.5.3 Opportunities
1.6 Industry News and Policies by Regions
  1.6.1 Industry News
  1.6.2 Industry Policies

2 INDUSTRY CHAIN ANALYSIS

2.1 Upstream Raw Material Suppliers of Stimulants Drugs Analysis
2.2 Major Players of Stimulants Drugs
  2.2.1 Major Players Manufacturing Base and Market Share of Stimulants Drugs in 2016
  2.2.2 Major Players Product Types in 2016
2.3 Stimulants Drugs Manufacturing Cost Structure Analysis
  2.3.1 Production Process Analysis
  2.3.2 Manufacturing Cost Structure of Stimulants Drugs
  2.3.3 Raw Material Cost of Stimulants Drugs
  2.3.4 Labor Cost of Stimulants Drugs
2.4 Market Channel Analysis of Stimulants Drugs
2.5 Major Downstream Buyers of Stimulants Drugs Analysis

3 GLOBAL STIMULANTS DRUGS MARKET, BY TYPE

3.1 Analysis of Market Status and Feature by Type
3.2 Global Stimulants Drugs Value ($) and Market Share by Type (2012-2017)
3.3 Global Stimulants Drugs Production and Market Share by Type (2012-2017)
3.4 Global Stimulants Drugs Value ($) and Growth Rate by Type (2012-2017)
3.5 Global Stimulants Drugs Price Analysis by Type (2012-2017)

4 STIMULANTS DRUGS MARKET, BY APPLICATION

4.1 Downstream Market Overview
4.2 Global Stimulants Drugs Consumption and Market Share by Application (2012-2017)
4.3 Downstream Buyers by Application
4.4 Global Stimulants Drugs Consumption and Growth Rate by Application (2012-2017)

5 GLOBAL STIMULANTS DRUGS PRODUCTION, VALUE ($) BY REGION (2012-2017)

5.1 Global Stimulants Drugs Value ($) and Market Share by Region (2012-2017)
5.2 Global Stimulants Drugs Production and Market Share by Region (2012-2017)
5.3 Global Stimulants Drugs Production, Value ($), Price and Gross Margin (2012-2017)
5.4 North America Stimulants Drugs Production, Value ($), Price and Gross Margin (2012-2017)
5.5 Europe Stimulants Drugs Production, Value ($), Price and Gross Margin (2012-2017)
5.6 China Stimulants Drugs Production, Value ($), Price and Gross Margin (2012-2017)
5.7 Japan Stimulants Drugs Production, Value ($), Price and Gross Margin (2012-2017)
5.8 Middle East & Africa Stimulants Drugs Production, Value ($), Price and Gross Margin (2012-2017)
5.9 India Stimulants Drugs Production, Value ($), Price and Gross Margin (2012-2017)
5.10 South America Stimulants Drugs Production, Value ($), Price and Gross Margin (2012-2017)

6 GLOBAL STIMULANTS DRUGS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

6.1 Global Stimulants Drugs Consumption by Regions (2012-2017)
6.2 North America Stimulants Drugs Production, Consumption, Export, Import (2012-2017)
6.3 Europe Stimulants Drugs Production, Consumption, Export, Import (2012-2017)
6.4 China Stimulants Drugs Production, Consumption, Export, Import (2012-2017)
6.5 Japan Stimulants Drugs Production, Consumption, Export, Import (2012-2017)
6.6 Middle East & Africa Stimulants Drugs Production, Consumption, Export, Import (2012-2017)
6.7 India Stimulants Drugs Production, Consumption, Export, Import (2012-2017)
6.8 South America Stimulants Drugs Production, Consumption, Export, Import (2012-2017)

7 GLOBAL STIMULANTS DRUGS MARKET STATUS AND SWOT ANALYSIS BY REGIONS

7.1 North America Stimulants Drugs Market Status and SWOT Analysis
7.2 Europe Stimulants Drugs Market Status and SWOT Analysis
7.3 China Stimulants Drugs Market Status and SWOT Analysis
7.4 Japan Stimulants Drugs Market Status and SWOT Analysis
7.5 Middle East & Africa Stimulants Drugs Market Status and SWOT Analysis
7.6 India Stimulants Drugs Market Status and SWOT Analysis
7.7 South America Stimulants Drugs Market Status and SWOT Analysis

8 COMPETITIVE LANDSCAPE

8.1 Competitive Profile
8.2 NEOS Therapeutics
  8.2.1 Company Profiles
  8.2.2 Stimulants Drugs Product Introduction and Market Positioning
    8.2.2.1 Product Introduction
    8.2.2.2 Market Positioning and Target Customers
  8.2.3 NEOS Therapeutics Production, Value ($), Price, Gross Margin 2012-2017E
  8.2.4 NEOS Therapeutics Market Share of Stimulants Drugs Segmented by Region in 2016
8.3 Teva
  8.3.1 Company Profiles
  8.3.2 Stimulants Drugs Product Introduction and Market Positioning
    8.3.2.1 Product Introduction
    8.3.2.2 Market Positioning and Target Customers
  8.3.3 Teva Production, Value ($), Price, Gross Margin 2012-2017E
  8.3.4 Teva Market Share of Stimulants Drugs Segmented by Region in 2016
8.4 Shire
  8.4.1 Company Profiles
  8.4.2 Stimulants Drugs Product Introduction and Market Positioning
    8.4.2.1 Product Introduction
    8.4.2.2 Market Positioning and Target Customers
  8.4.3 Shire Production, Value ($), Price, Gross Margin 2012-2017E
  8.4.4 Shire Market Share of Stimulants Drugs Segmented by Region in 2016
8.5 Novartis
  8.5.1 Company Profiles
  8.5.2 Stimulants Drugs Product Introduction and Market Positioning
    8.5.2.1 Product Introduction
    8.5.2.2 Market Positioning and Target Customers
  8.5.3 Novartis Production, Value ($), Price, Gross Margin 2012-2017E
  8.5.4 Novartis Market Share of Stimulants Drugs Segmented by Region in 2016
8.6 Arbor Pharmaceuticals
  8.6.1 Company Profiles
  8.6.2 Stimulants Drugs Product Introduction and Market Positioning
    8.6.2.1 Product Introduction
    8.6.2.2 Market Positioning and Target Customers
  8.6.3 Arbor Pharmaceuticals Production, Value ($), Price, Gross Margin 2012-2017E
  8.6.4 Arbor Pharmaceuticals Market Share of Stimulants Drugs Segmented by Region in 2016
8.7 Noven Therapeutics
  8.7.1 Company Profiles
  8.7.2 Stimulants Drugs Product Introduction and Market Positioning
    8.7.2.1 Product Introduction
    8.7.2.2 Market Positioning and Target Customers
  8.7.3 Noven Therapeutics Production, Value ($), Price, Gross Margin 2012-2017E
  8.7.4 Noven Therapeutics Market Share of Stimulants Drugs Segmented by Region in 2016
8.8 Janssen
  8.8.1 Company Profiles
  8.8.2 Stimulants Drugs Product Introduction and Market Positioning
    8.8.2.1 Product Introduction
    8.8.2.2 Market Positioning and Target Customers
  8.8.3 Janssen Production, Value ($), Price, Gross Margin 2012-2017E
  8.8.4 Janssen Market Share of Stimulants Drugs Segmented by Region in 2016
8.9 Amedra Pharms
  8.9.1 Company Profiles
  8.9.2 Stimulants Drugs Product Introduction and Market Positioning
    8.9.2.1 Product Introduction
    8.9.2.2 Market Positioning and Target Customers
  8.9.3 Amedra Pharms Production, Value ($), Price, Gross Margin 2012-2017E
  8.9.4 Amedra Pharms Market Share of Stimulants Drugs Segmented by Region in 2016
8.10 Tocris
  8.10.1 Company Profiles
  8.10.2 Stimulants Drugs Product Introduction and Market Positioning
    8.10.2.1 Product Introduction
    8.10.2.2 Market Positioning and Target Customers
  8.10.3 Tocris Production, Value ($), Price, Gross Margin 2012-2017E
  8.10.4 Tocris Market Share of Stimulants Drugs Segmented by Region in 2016

9 GLOBAL STIMULANTS DRUGS MARKET ANALYSIS AND FORECAST BY TYPE AND APPLICATION

9.1 Global Stimulants Drugs Market Value ($) & Volume Forecast, by Type (2017-2022)
  9.1.1 Tablet Market Value ($) and Volume Forecast (2017-2022)
  9.1.2 Injection Market Value ($) and Volume Forecast (2017-2022)
9.2 Global Stimulants Drugs Market Value ($) & Volume Forecast, by Application (2017-2022)
  9.2.1 Adult Market Value ($) and Volume Forecast (2017-2022)
  9.2.2 Child Market Value ($) and Volume Forecast (2017-2022)

10 STIMULANTS DRUGS MARKET ANALYSIS AND FORECAST BY REGION

10.1 North America Market Value ($) and Consumption Forecast (2017-2022)
10.2 Europe Market Value ($) and Consumption Forecast (2017-2022)
10.3 China Market Value ($) and Consumption Forecast (2017-2022)
10.4 Japan Market Value ($) and Consumption Forecast (2017-2022)
10.5 Middle East & Africa Market Value ($) and Consumption Forecast (2017-2022)
10.6 India Market Value ($) and Consumption Forecast (2017-2022)
10.7 South America Market Value ($) and Consumption Forecast (2017-2022)

11 NEW PROJECT FEASIBILITY ANALYSIS

11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment

12 RESEARCH FINDING AND CONCLUSION

13 APPENDIX

13.1 Discussion Guide
13.2 Knowledge Store: Maia Subscription Portal
13.3 Research Data Source
13.4 Research Assumptions and Acronyms Used

List Of Tables

LIST OF TABLES AND FIGURES


Figure Product Picture of Stimulants Drugs
Table Product Specification of Stimulants Drugs
Figure Market Concentration Ratio and Market Maturity Analysis of Stimulants Drugs
Figure Global Stimulants Drugs Value ($) and Growth Rate from 2012-2022
Table Different Types of Stimulants Drugs
Figure Global Stimulants Drugs Value ($) Segment by Type from 2012-2017
Figure Tablet Picture
Figure Injection Picture
Table Different Applications of Stimulants Drugs
Figure Global Stimulants Drugs Value ($) Segment by Applications from 2012-2017
Figure Adult Picture
Figure Child Picture
Table Research Regions of Stimulants Drugs
Figure North America Stimulants Drugs Production Value ($) and Growth Rate (2012-2017)
Figure Europe Stimulants Drugs Production Value ($) and Growth Rate (2012-2017)
Table China Stimulants Drugs Production Value ($) and Growth Rate (2012-2017)
Table Japan Stimulants Drugs Production Value ($) and Growth Rate (2012-2017)
Table Middle East & Africa Stimulants Drugs Production Value ($) and Growth Rate (2012-2017)
Table India Stimulants Drugs Production Value ($) and Growth Rate (2012-2017)
Table South America Stimulants Drugs Production Value ($) and Growth Rate (2012-2017)
Table Emerging Countries of Stimulants Drugs
Table Growing Market of Stimulants Drugs
Figure Industry Chain Analysis of Stimulants Drugs
Table Upstream Raw Material Suppliers of Stimulants Drugs with Contact Information
Table Major Players Manufacturing Base and Market Share ($) of Stimulants Drugs in 2016
Table Major Players Stimulants Drugs Product Types in 2016
Figure Production Process of Stimulants Drugs
Figure Manufacturing Cost Structure of Stimulants Drugs
Figure Channel Status of Stimulants Drugs
Table Major Distributors of Stimulants Drugs with Contact Information
Table Major Downstream Buyers of Stimulants Drugs with Contact Information
Table Analysis of Market Status and Feature by Type
Table Global Stimulants Drugs Value ($) by Type (2012-2017)
Table Global Stimulants Drugs Value ($) Share by Type (2012-2017)
Figure Global Stimulants Drugs Value ($) Share by Type (2012-2017)
Table Global Stimulants Drugs Production by Type (2012-2017)
Table Global Stimulants Drugs Production Share by Type (2012-2017)
Figure Global Stimulants Drugs Production Share by Type (2012-2017)
Figure Global Stimulants Drugs Value ($) and Growth Rate of Tablet
Figure Global Stimulants Drugs Value ($) and Growth Rate of Injection
Table Global Stimulants Drugs Price by Type (2012-2017)
Figure Downstream Market Overview
Table Global Stimulants Drugs Consumption by Application (2012-2017)
Table Global Stimulants Drugs Consumption Market Share by Application (2012-2017)
Figure Global Stimulants Drugs Consumption Market Share by Application (2012-2017)
Table Downstream Buyers Introduction by Application
Figure Global Stimulants Drugs Consumption and Growth Rate of Adult (2012-2017)
Figure Global Stimulants Drugs Consumption and Growth Rate of Child (2012-2017)
Table Global Stimulants Drugs Value ($) by Region (2012-2017)
Table Global Stimulants Drugs Value ($) Market Share by Region (2012-2017)
Figure Global Stimulants Drugs Value ($) Market Share by Region (2012-2017)
Table Global Stimulants Drugs Production by Region (2012-2017)
Table Global Stimulants Drugs Production Market Share by Region (2012-2017)
Figure Global Stimulants Drugs Production Market Share by Region (2012-2017)
Table Global Stimulants Drugs Production, Value ($), Price and Gross Margin (2012-2017)
Table North America Stimulants Drugs Production, Value ($), Price and Gross Margin (2012-2017)
Table Europe Stimulants Drugs Production, Value ($), Price and Gross Margin (2012-2017)
Table China Stimulants Drugs Production, Value ($), Price and Gross Margin (2012-2017)
Table Japan Stimulants Drugs Production, Value ($), Price and Gross Margin (2012-2017)
Table Middle East & Africa Stimulants Drugs Production, Value ($), Price and Gross Margin (2012-2017)
Table India Stimulants Drugs Production, Value ($), Price and Gross Margin (2012-2017)
Table South America Stimulants Drugs Production, Value ($), Price and Gross Margin (2012-2017)
Table Global Stimulants Drugs Consumption by Regions (2012-2017)
Figure Global Stimulants Drugs Consumption Share by Regions (2012-2017)
Table North America Stimulants Drugs Production, Consumption, Export, Import (2012-2017)
Table Europe Stimulants Drugs Production, Consumption, Export, Import (2012-2017)
Table China Stimulants Drugs Production, Consumption, Export, Import (2012-2017)
Table Japan Stimulants Drugs Production, Consumption, Export, Import (2012-2017)
Table Middle East & Africa Stimulants Drugs Production, Consumption, Export, Import (2012-2017)
Table India Stimulants Drugs Production, Consumption, Export, Import (2012-2017)
Table South America Stimulants Drugs Production, Consumption, Export, Import (2012-2017)
Figure North America Stimulants Drugs Production and Growth Rate Analysis
Figure North America Stimulants Drugs Consumption and Growth Rate Analysis
Figure North America Stimulants Drugs SWOT Analysis
Figure Europe Stimulants Drugs Production and Growth Rate Analysis
Figure Europe Stimulants Drugs Consumption and Growth Rate Analysis
Figure Europe Stimulants Drugs SWOT Analysis
Figure China Stimulants Drugs Production and Growth Rate Analysis
Figure China Stimulants Drugs Consumption and Growth Rate Analysis
Figure China Stimulants Drugs SWOT Analysis
Figure Japan Stimulants Drugs Production and Growth Rate Analysis
Figure Japan Stimulants Drugs Consumption and Growth Rate Analysis
Figure Japan Stimulants Drugs SWOT Analysis
Figure Middle East & Africa Stimulants Drugs Production and Growth Rate Analysis
Figure Middle East & Africa Stimulants Drugs Consumption and Growth Rate Analysis
Figure Middle East & Africa Stimulants Drugs SWOT Analysis
Figure India Stimulants Drugs Production and Growth Rate Analysis
Figure India Stimulants Drugs Consumption and Growth Rate Analysis
Figure India Stimulants Drugs SWOT Analysis
Figure South America Stimulants Drugs Production and Growth Rate Analysis
Figure South America Stimulants Drugs Consumption and Growth Rate Analysis
Figure South America Stimulants Drugs SWOT Analysis
Figure Competitive Matrix and Pattern Characteristics of Stimulants Drugs Market
Figure Top 3 Market Share of Stimulants Drugs Companies
Figure Top 6 Market Share of Stimulants Drugs Companies
Table Mergers, Acquisitions and Expansion Analysis
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table NEOS Therapeutics Production, Value ($), Price, Gross Margin 2012-2017E
Figure NEOS Therapeutics Production and Growth Rate
Figure NEOS Therapeutics Value ($) Market Share 2012-2017E
Figure NEOS Therapeutics Market Share of Stimulants Drugs Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Teva Production, Value ($), Price, Gross Margin 2012-2017E
Figure Teva Production and Growth Rate
Figure Teva Value ($) Market Share 2012-2017E
Figure Teva Market Share of Stimulants Drugs Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Shire Production, Value ($), Price, Gross Margin 2012-2017E
Figure Shire Production and Growth Rate
Figure Shire Value ($) Market Share 2012-2017E
Figure Shire Market Share of Stimulants Drugs Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Novartis Production, Value ($), Price, Gross Margin 2012-2017E
Figure Novartis Production and Growth Rate
Figure Novartis Value ($) Market Share 2012-2017E
Figure Novartis Market Share of Stimulants Drugs Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Arbor Pharmaceuticals Production, Value ($), Price, Gross Margin 2012-2017E
Figure Arbor Pharmaceuticals Production and Growth Rate
Figure Arbor Pharmaceuticals Value ($) Market Share 2012-2017E
Figure Arbor Pharmaceuticals Market Share of Stimulants Drugs Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Noven Therapeutics Production, Value ($), Price, Gross Margin 2012-2017E
Figure Noven Therapeutics Production and Growth Rate
Figure Noven Therapeutics Value ($) Market Share 2012-2017E
Figure Noven Therapeutics Market Share of Stimulants Drugs Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Janssen Production, Value ($), Price, Gross Margin 2012-2017E
Figure Janssen Production and Growth Rate
Figure Janssen Value ($) Market Share 2012-2017E
Figure Janssen Market Share of Stimulants Drugs Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Amedra Pharms Production, Value ($), Price, Gross Margin 2012-2017E
Figure Amedra Pharms Production and Growth Rate
Figure Amedra Pharms Value ($) Market Share 2012-2017E
Figure Amedra Pharms Market Share of Stimulants Drugs Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Tocris Production, Value ($), Price, Gross Margin 2012-2017E
Figure Tocris Production and Growth Rate
Figure Tocris Value ($) Market Share 2012-2017E
Figure Tocris Market Share of Stimulants Drugs Segmented by Region in 2016
Table Global Stimulants Drugs Market Value ($) Forecast, by Type
Table Global Stimulants Drugs Market Volume Forecast, by Type
Figure Global Stimulants Drugs Market Value ($) and Growth Rate Forecast of Tablet (2017-2022)
Figure Global Stimulants Drugs Market Volume and Growth Rate Forecast of Tablet (2017-2022)
Figure Global Stimulants Drugs Market Value ($) and Growth Rate Forecast of Injection (2017-2022)
Figure Global Stimulants Drugs Market Volume and Growth Rate Forecast of Injection (2017-2022)
Table Global Market Value ($) Forecast by Application (2017-2022)
Table Global Market Volume Forecast by Application (2017-2022)
Figure Global Stimulants Drugs Consumption and Growth Rate of Adult (2012-2017)
Figure Global Stimulants Drugs Consumption and Growth Rate of Child (2012-2017)
Figure Market Value ($) and Growth Rate Forecast of Child (2017-2022)
Figure Market Volume and Growth Rate Forecast of Child (2017-2022)
Figure North America Market Value ($) and Growth Rate Forecast (2017-2022)
Table North America Consumption and Growth Rate Forecast (2017-2022)
Figure Europe Market Value ($) and Growth Rate Forecast (2017-2022)
Table Europe Consumption and Growth Rate Forecast (2017-2022)
Figure China Market Value ($) and Growth Rate Forecast (2017-2022)
Table China Consumption and Growth Rate Forecast (2017-2022)
Figure Japan Market Value ($) and Growth Rate Forecast (2017-2022)
Table Japan Consumption and Growth Rate Forecast (2017-2022)
Figure Middle East & Africa Market Value ($) and Growth Rate Forecast (2017-2022)
Table Middle East & Africa Consumption and Growth Rate Forecast (2017-2022)
Figure India Market Value ($) and Growth Rate Forecast (2017-2022)
Table India Consumption and Growth Rate Forecast (2017-2022)
Figure South America Market Value ($) and Growth Rate Forecast (2017-2022)
Table South America Consumption and Growth Rate Forecast (2017-2022)
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery